- Patients who do not respond adequately to drug therapy or show side effects;
- Young patients who want to avoid long-term drug use;
- Patients with recurrent atrial fibrillation, flutter or supraventricular tachycardia complaints;
- Patients at risk of heart failure due to recurrent arrhythmias;
- Patients with a poor quality of life due to arrhythmia-related complaints.